10/2/2023 0 Comments High precision diagnostics![]() The growth of the Female Fertility Tracker market was mainly driven by the increasing R&D spending across the world, however latest scenario and economic slowdown have changed complete market dynamics. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.HTF Market Intelligence published a new research publication on Female Fertility Tracker Market Insights, to 2028" with 150+pages and enriched with self-explained Tables and charts in presentable format. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (). For more information about Avalon GloboCare, please visit Story continuesįor the latest updates on Avalon GloboCare’s developments, please follow our twitter at StatementsĬertain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding LSM. The Company also provides laboratory services, offering a broad portfolio of diagnostic tests including drug testing, toxicology, and a broad array of test services, from general bloodwork to anatomic pathology, and urine toxicology. Avalon is establishing a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services. By leveraging LSM’s experience and infrastructure, we expect to achieve significant synergies with respect to revenue growth and market share.”Īvalon GloboCare Corp. ![]() We continue to target laboratories with exceptional performance, positive revenue track records and niche-market advantages. “Our strategy is to take advantage of a unique roll-up opportunity within the highly fragmented market for laboratory testing and services. “This acquisition is just another step towards our goal of expanding LSM through acquisitions and strategic relationships,” commented, David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon. ![]() LSM is now operating this laboratory as a fully owned subsidiary and has invested growth capital for geographical expansion into the surrounding counties. Avalon owns a 40% interest in LSM.ĭE Labs is a CLIA-certified and COLA-accredited laboratory located in Houston, Texas that offers a wide range of high-quality testing, including drug testing, genetic testing, urinary testing and COVID-19 PCR testing. ![]() (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC (“LSM”), has acquired DE Laboratory LLC (“DE Labs”), which expands its penetration within Texas and provides significant potential growth opportunities for the combined company. DE Laboratory in Texas Performs 1,500 Lab Tests Per Month with Focus on Toxicology and Wellness Testing Expansion UnderwayįREEHOLD, N.J., J(GLOBE NEWSWIRE) - Avalon GloboCare Corp.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |